March 27, 2026

FDA Approval Advances Basal Insulin

Weekly dosing reduces injection frequency vs daily regimens, with phase 3 data supporting efficacy and class-consistent safety.

Conexiant

March 27, 2026

Hydration Intervention Did Not Reduce Stone Recurrence

A behavioral strategy modestly increased urine volume but did not lower symptomatic events over 2 years.

Conexiant

March 24, 2026

Ablation vs Surgery Outcomes for Small RCC

Minimally invasive therapy offers perioperative advantages in registry analysis.

Conexiant

March 24, 2026

Mammography AI Spots Vascular Signals

Routine breast imaging offers opportunity for cardiovascular risk assessment.

Conexiant

March 24, 2026

Review Supports Fluids, Diet to Prevent Recurrent Kidney Stones

A systematic review found low-strength evidence that increased fluid intake, a calcium-normal/higher, lower-protein, lower-sodium diet, and some drug therapies may reduce recurrent calcium stone events in adults; evidence was limited in children and absent for surveillance imaging.

Conexiant

March 23, 2026

Metabolic Acidosis Care Limited in Chronic Kidney Disease

Low testing rates may contribute to underdiagnosis and undertreatment in Japan

Conexiant

March 23, 2026

Renal Imaging Strategies Put to the Test

Noncontrast MRI technique evaluates renal tumor characterization in rapid acquisition.

Conexiant

March 18, 2026

Adjusted Calcium Is Lying — And Labs Keep Printing It

Choy et al. argue it's time to stop trusting a number that's been unreliable for fifty years.

Conexiant

March 17, 2026

Side Effects: When the Obvious Call Is the Wrong One

Dialysis, nicotine, caffeine, and tattoos — four studies that quietly rearrange what good clinical instinct looks like.

Conexiant

March 17, 2026

Aneurysmal Hemorrhage Triggers Systemic Effects

Researchers examine physiologic responses following rupture and link them to outcomes.

Conexiant